Invivyd, Inc.
US ˙ NasdaqGM ˙ US00534A1025

SecurityIVVD / Invivyd, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership819,968 shares
Latest Disclosed Value $ 1,065,958
Squarepoint Ops LLC reports 300.78% increase in ownership of IVVD / Invivyd, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 819,968 shares of Invivyd, Inc. (US:IVVD) valued at $1,065,958 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 204,591 shares of Invivyd, Inc.. This represents a change in shares of 300.78% during the quarter. The current value of the position is $901,965 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INVIVYD COM 00534A102 819,968 615,377 300.78 1,066 110.89 0.0013
2026-02-13 2025-12-31 13F INVIVYD COM 00534A102 204,591 96,760 89.73 505 327.97 0.0005
2025-11-14 2025-09-30 13F INVIVYD COM 00534A102 107,831 70,508 188.91 119 353.85 0.0001
2025-08-27 2025-06-30 13F/A-1 INVIVYD COM 00534A102 37,323 37,323 27 0.0000
2025-08-14 2025-06-30 13F INVIVYD COM 00534A102 37,323 37,323 27 0.0000
2024-11-14 2024-09-30 13F INVIVYD COM 00534A102 0 -74,565 -100.00 0 -100.00
2024-08-14 2024-06-30 13F INVIVYD COM 00534A102 74,565 -209,896 -73.79 82 -93.51 0.0001
2024-05-15 2024-03-31 13F INVIVYD COM 00534A102 284,461 182,071 177.82 1,263 213.40 0.0022
2024-02-14 2023-12-31 13F INVIVYD COM 00534A102 102,390 -104,027 -50.40 403 15.14 0.0008
2023-11-14 2023-09-30 13F INVIVYD COM 00534A102 206,417 -12,310 -5.63 351 52.84 0.0009
2023-08-14 2023-06-30 13F INVIVYD COM 00534A102 218,727 203,890 1,374.20 230 1,247.06 0.0007
2023-05-15 2023-03-31 13F INVIVYD COM 00534A102 14,837 -35,703 -70.64 18 -77.33 0.0001
2023-02-14 2022-12-31 13F INVIVYD COM 00534A102 50,540 50,540 76 0.0003
2022-11-14 2022-09-30 13F ADAGIO THERAPEUTICS COM 00534A102 0 -10,800 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ADAGIO THERAPEUTICS COM 00534A102 10,800 -5,423 -33.43 35 -52.70 0.0002
2022-05-16 2022-03-31 13F ADAGIO THERAPEUTICS COM 00534A102 16,223 -347 -2.09 74 -38.33 0.0003
2022-02-14 2021-12-31 13F ADAGIO THERAPEUTICS COM 00534A102 16,570 16,570 120 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.